Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol Maleate Inhalation Powder BE in COPD
CTR20213115Phase 3Completed
- Sponsor
- Joincare Pharmaceutical
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indacaterol in chronic obstructive pulmonary disease (COPD), sponsored by Joincare Pharmaceutical. Started Dec 2021; status: completed.
02
Drugs
indacaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20213115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213115.